Skip to main content
. 2012 Dec 12;2012(12):CD001423. doi: 10.1002/14651858.CD001423.pub3
Date Event Description
6 May 2011 Amended For this update (2012) we added adverse events (harms) to Secondary outcomes.
4 March 2010 Amended Under 'Feedback/1 Anna Rita Bilia, et al, 31 August 2009/Summary/Reply', a clause read: "and by 0.72 in the placebo group (95 percent confidence interval, ‐1.40 to ‐0.04) ('Table 2')." It has been changed to "and by 0.72 in the placebo group (95 percent confidence interval, ‐1.40 to ‐0.04) ('Table 2')."
29 September 2008 New citation required and conclusions have changed We have modified our findings of the efficacy of Serenoa repens.
10 July 2008 New search has been performed This is a substantial update with 9 new trials.
25 March 2008 Amended Converted to new review format.
21 December 2007 New citation required and conclusions have changed Substantive amendment